共 8 条
[1]
Thalidomide and congenital abnormalities. McBride WG. The Lancet . 1961
[2]
Drug Safety in Pregancy. Chambers CD,Andrew EB. In:Mann R,Andrew EB,eds.Pharmacovigilance.1st ed.John Wiley&Sons Ltd . 2002
[3]
Drug Safety in Pregancy. Chambers CD,Andrew EB. In:Mann R,Andrew EB,eds.Pharmacovigilance.1st ed.John Wiley&Sons Ltd . 2002
[4]
Prescription of drugs during pregnancy in France. Lacroix I,Damase-Michel C,Lapeyre-Mestre M,et al. The Lancet . 2000
[5]
Pregnancy outcomes following systemic prenatal acyclovir exposure:Conclusions from the international acyclovir pregnancy registry,1984-1999. Stone KM,Reiff-Eldridge R,White AD,et al. Birth Defects Res A Clin Mol Teratol . 2004
[6]
Pregnancy Exposure Registries. Kennedy D.L,Uhl K,Kweder S.L. Drug Safety . 2004
[7]
Effects of first-trimester flu-oxetine exposure on the newborn. Goldstein DI,Corbin LA,Sundell KL. Obstetrics and Gynecology . 1997
[8]
Epidemiology of unintended pregnancy and contracep-tive use. Forrest JD. American Journal of Obstetrics and Gynecology . 1994